Cargando…
Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
Triple-negative breast cancer is a combative cancer type with a highly inflated histological grade that leads to poor theragnostic value. Gene, protein, and receptor-specific targets have shown effective clinical outcomes in patients with TNBC. Cells are frequently exposed to DNA-damaging agents. DN...
Autores principales: | Singh, Desh Deepak, Parveen, Amna, Yadav, Dharmendra Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8614648/ https://www.ncbi.nlm.nih.gov/pubmed/34829741 http://dx.doi.org/10.3390/biomedicines9111512 |
Ejemplares similares
-
TNBC: Potential Targeting of Multiple Receptors for a Therapeutic Breakthrough, Nanomedicine, and Immunotherapy
por: Singh, Desh Deepak, et al.
Publicado: (2021) -
SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021) -
Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2022) -
Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors
por: Singh, Desh Deepak, et al.
Publicado: (2023)